Archive for May, 2006

Smoking cessation drug approved by the FDA

The U.S. Food and Drug Administration (FDA) has approved Chantix (varenicline tartrate) to help cigarette smokers stop smoking. Chantix is an oral tablet to be taken twice daily for 12 weeks. It will be available by prescription only and is not recommended for children under 18 years of age.

The active ingredient in Chantix, varenicline tartrate, acts at sites in the brain affected by nicotine and may help those who wish to give up smoking in two ways: by providing some nicotine effects to ease the withdrawal symptoms and by blocking the effects of nicotine from cigarettes if they resume smoking.

via FDA, May 2006 

Potent carcinogen found in the urine of babies who have been exposed to second-hand smoke

In a recent study, nearly half the infants exposed to second-hand smoke from their parents’ cigarettes showed evidence of a significant carcinogen in their urine. This carcinogen is known to cause lung cancer.

via Cancer Epidemiology Biomarkers and Prevention, May 2006

Daily Aspirin Therapy Tops the List of Affordable and Effective Preventive Measures

A recent report by the National Commission on Prevention Priorities, has identified the top 25 clinical services that are the most effective, yet relatively affordable.

Topping the list of of affordable and effective preventive measures was daily aspirin therapy. Men older than 40 and women older than 50, and those with any others at risk for heart disease should ask their doctors about taking one aspirin on a daily basis. There are important precautions, however, with respect to aspirin, so it’s important to consult with your doctor before starting aspirin therapy. May 2006